Septicemia clinical trials
57 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- An Acupuncture Study for People At High Risk for Sepsis
- A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
- Vancomycin and Acute Kidney Injury in Sepsis Treatment - Intervention
- External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
- Assessment for Implementation Methods in Sepsis
- BLOOM: Pragmatic Feasibility Trial
- Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- MID-STEP (MIDodrine for Sepsis Treatment and Early vasoPressor Weaning) Trial
- The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS)
- Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
- A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02)
- MyokinE100 System: Closed Loop Electrical Muscle Stimulation to Mitigate ICU Acquired Weakness in Medical ICU Patients
- Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
- The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
- Hemorrhage Elimination During Lumbar Puncture Using Ultrasound Measurements (HELPUS)
- TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections
- Multicenter Symphony™ IL-6 Monitoring Sepsis ED Pilot Study
- Smart Discharges for Older Children
- PIVO Use for Blood Cultures in the Emergency Department
- Assessing Immune Dysfunction in Sepsis
- Dynamics of Organ Damage and Immune Exhaustion During Sepsis
- Role of Transposable Elements in Septic Immune Aging
- Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Study
- QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry
- Predicton of Sepsis Recovery Performance Subtypes Pilot Study
- Prediction of Rehospitalization Following a Sepsis Admission Using a Wearable Biopatch
- Change in MAPSE During Treatment of Sepsis
- Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis
- Expression Profiles of Integrin αDβ2 on Neutrophils in Sepsis
- Neutrophil Phenotypic Profiling and Organ Injury Assessment in Patients With Sepsis
- Modulation of Molecular Fingerprinting in Pediatric Sepsis
- Recovery of Physical Function After Critical Illness In Older Adults
- Safe and Explainable AI
- The APS Phenotyping Study
- Pathological Myeloid Activation After Sepsis and Trauma
- Biomarkers in Infection
- Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- Microbiome Dysfunction in Surgical Intensive Care Unit Survivors
- End Diagnostic Overshadowing:Addressing Ableism in Diagnoses
- Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
- UMMS Sepsis Early Prediction Score (SEPSys) and RESCUE Score Combined Clinical Trial
- Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis
- Evaluation of Pediatric eCART Implementation
- The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- The Effects of Endotracheal Suctioning on Pain and Serum Markers
- OPT101 in Patients With Community Acquired Pneumonia (CAP) With Sepsis
- Point-of-Care AI Assistance and Critical Care Outcomes: A Randomized Trial
- Comparison of Sepsis Prediction Algorithms
- Biomarker-enhanced Artificial Intelligence Based Pediatric Sepsis Screening Tool
- Alveolar Dead Space as Predictor of Organ Failure in Severe Sepsis
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Septicemia” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.